View as web page here.
Sunday_Newsletter_ARK.png

Hi 

 

It's Monday, July 13, 2020. Please enjoy ARK's weekly newsletter curated by our thematic analysts and designed to keep you engaged with disruptive innovation.

Tesla Continues to Gain Market Share in China and Around the World

By Sam Korus | @skorusARK

 

During the first half of 2020, Tesla’s market share of battery electric vehicles in China reached 21%, up from 6% for the year in 2019 and 2% in 2018, as shown below. It appears that concerns about Tesla’s ability to sell lower-end cars in China have been misplaced.


On a global basis during the first half of the year through May, Tesla’s market share increased roughly 300 basis points from 23% on average in 2019 to 26%, as shown below. While many investors used to ask what will happen to Tesla when traditional automakers start making and selling electric vehicles, ARK now wonders how high Tesla’s market share will go, a remarkable turn given that our base case assumption is in the opposite direction, 19%, for 2024.

Liquid Biopsies Designed to Detect Early Stage Cancer Could Save Thousands of Lives

By Simon Barnett | @sbarnettARK

 

Cancer is a progressive disease. Virtually all solid tumors begin as benign lesions that progress at an arbitrary rate, culminating in metastatic disease. While metastatic cancers comprise the minority of new diagnoses, they account for the majority of deaths over five years.

 

We believe that liquid biopsies designed to detect early stage cancer, such as those offered by GRAIL and Thrive Earlier Detection, could improve the cancer mortality rate dramatically. Conceptually, liquid biopsies improve mortality by shifting diagnoses from metastatic to local or regional, increasing the odds of survival substantially. With liquid biopsies, if local, regional, and metastatic cases were to comprise 70%, 25%, and 5% of new diagnoses, respectively, then according to our estimates, cancer screening individuals with no other screening alternative - like patients with pancreatic cancer - could result in 31,000 fewer cancer deaths per year in the US alone, as shown on the left in the chart below. In other words, liquid biopsies could save an equivalent of the number of lives lost each year to automobile accidents. From another perspective, screening individuals aged 40+ years could save as many as 85,000 lives per year, more than the number of lives lost to diabetes each year, as shown in the right on the chart below.

 

ARK plans to release its model for cancer screening and a comprehensive white paper in the near future.

 

Cellectis’ Allogenic CAR-T Cell Therapy is Put on Hold by the FDA

By Ali Urman | @aurmanARK

 

This week, in response to a patient’s death, the FDA put Cellectis’ (CLLS) allogeneic - or donor-derived - CAR-T cell therapy for late stage multiple myeloma (MM) on hold. In our view, the cardiac arrest was not related to the cell therapy for a few reasons. First, having failed multiple lines of therapy, patients in Phase I clinical trials often are extremely sick, the reason they agree to participate in trials which have not been tested for safety and efficacy in humans. The patient who died had undergone several therapies, including autologous CAR-T cell therapy, without success. Moreover, the adverse event happened on day 25, three days before the clinical end point would have been met, at which time Cellectis would not have had to report any adverse events. Finally, the patient was the first to be treated at the higher of two doses. Cellectis disclosed they were planning to expand enrollment at the lower dose, 1 million cells/kg before the patient death. In our view, this clinical hold is unlikely to impact Cellectis’ or Allogene’s other CAR-T programs, the latter’s licensed from Cellectis.

The US Upfront Market for Television Advertising Is Plummeting This Year

By Nick Grous | @GrousARK

 

Historically, the “upfront market” for television advertising has accounted for 25-30% of the annual $70 billion in US TV ad budgets. The upfront market typically takes place in the late spring/early summer when the major TV networks showcase their fall programming and woo advertisers to buy ad slots ahead of the season.

 

Because of the coronavirus crisis, the upfront TV advertising market has hit a wall. Given the uncertainty surrounding the future of live sports and fall programming, advertisers have slashed budgets for linear TV. EMarketer, for example, expects the upfront market to collapse by roughly 27% this year.

After years of increasing in the face of declining viewership, ad spending on linear TV could be descending into years of secular decline. The coronavirus might have tripped the switch, but streaming TV could seal the deal.

 

While EMarketer expects a rebound next year, we do not. With plenty of new streaming options, accelerated cord cutting, and programming uncertainty, advertisers are likely to gravitate, if not flee, to more efficient platforms. ARK believes that, from a peak of $70 billion in 2019, the linear TV ad market could collapse by more than 50% to $34 billion during the next five years.

Slack May Have Found Its North Star Despite Losing to Microsoft’s Teams

By James Wang | @jwangARK

 

Though first to market with a business chat program, Slack has been crushed by Microsoft’s Teams app. Teams has more than 75 million daily active users (DAUs) compared to Slack’s 12 million. Using its old play book of copying and bundling, Microsoft seems to have vanquished yet another startup.

 

Not so fast. While Microsoft has been integrating Teams with Office 365 and adding features like video conferencing, Slack has been building Connect for the last four years. Connect takes the Slack model of shared channels a step further, allowing up to 20 organizations to collaborate inside the same Slack channel, closing the communication gaps between and among large teams just in time for a world working remotely at home.

 

Contrasting the difference between Microsoft’s and Slack’s strategies, Ben Thompson of Stratechery wrote: “...while Microsoft is busy building an operating system in the cloud, Slack has decided to build the enterprise social network. Or, to put it in visual terms, Microsoft is a vertical company, and Slack has gone fully horizontal.”

 

We believe no company has succeeded in building a truly social network for businesses. Perhaps the closest is Bloomberg in the finance industry. If Slack were to replicate its success across industries and organizations - a big if - it could become the most impactful social network since Facebook.

In Other Innovation News

Tik-Tok has revived internet meme cryptocurrency, Dogecoin. Over 10 million videos with the hashtag "dogecoin" have been created on TikTok to boost its price. Google search interest volumes for Dogecoin have skyrocketed to all-time highs, while Dogecoin’s price and trading volume have increased 2- and 210-fold, respectively. We invite you to find news more on the "Dogemania" here.

 

Be kind, stay safe, and we hope you find this information useful.


ARK's statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. For a list of all purchases and sales made by ARK for client accounts during the past year that could be considered by the SEC as recommendations, click here. It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities in this list. For full disclosures, click here.


 

 

3 East 28th Street, Floor 7
New York, NY 10016 United States

You received this email because you are subscribed to Research Newsletters from ARK Investment Management LLC.
Unsubscribe from ARK emails or choose the types of emails you want to receive. Unsubscribe from all.
 

This Newsletter is for informational purposes only and does not constitute, either explicitly or implicitly, any provision of services or products by ARK Investment Management LLC (“ARK”). Investors should determine for themselves whether a particular service or product is suitable for their investment needs or should seek such professional advice for their particular situation. All content is original and has been researched and produced by ARK unless otherwise stated therein. No part of the content may be reproduced in any form, or referred to in any other publication, without the express written permission of ARK. All statements made regarding companies, securities or other financial information contained in the content or articles relating to ARK are strictly beliefs and points of view held by ARK and are not endorsements of any company or security or recommendations to buy or sell any security. By visiting and/or otherwise using the ARK website in any way, you indicate that you understand and accept the terms of use as set forth on the website and agree to be bound by them. If you do not agree to the terms of use of the website, please do no access the website or any pages thereof. Any descriptions of, references to, or links to other products, publications or services does not constitute an endorsement, authorization, sponsorship by or affiliation with ARK with respect to any linked site or its sponsor, unless expressly stated by ARK. Any such information, products or sites have not necessarily been reviewed by ARK and are provided or maintained by third parties over whom ARK exercises no control. ARK expressly disclaims any responsibility for the content, the accuracy of the information, and/or quality of products or services provided by or advertised on these third-party sites.